Similar articles for PMID: 22374203

Year	Number of Results
1975	1
1987	1
1995	2
1996	3
1997	1
1998	4
1999	10
2000	6
2001	13
2002	9
2003	7
2004	12
2005	15
2006	16
2007	18
2008	12
2009	17
2010	15
2011	13
2012	24
2013	21
2014	18
2015	21
2016	21
2017	21
2018	18
2019	26
2020	22
2021	17
2022	20
2023	4
2024	0

1

Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.

Okayama Y, Kashiwakura J, Sasaki-Sakamoto T, Matsumoto K, Hashimoto N, Ohmori K, Kawakami T, Saito H, Ra C. Okayama Y, et al. Ann Allergy Asthma Immunol. 2012 Mar;108(3):188-94. doi: 10.1016/j.anai.2012.01.009. Ann Allergy Asthma Immunol. 2012. PMID: 22374203

2

FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.

Safaralizadeh R, Soheili ZS, Deezagi A, Pourpak Z, Samiei S, Moin M. Safaralizadeh R, et al. Iran J Allergy Asthma Immunol. 2009 Dec;8(4):177-83. Iran J Allergy Asthma Immunol. 2009. PMID: 20404387 Free article.

3

Regulation of IgE-dependent zinc release from human mast cells.

Nakashima-Kaneda K, Matsuda A, Mizuguchi H, Sasaki-Sakamoto T, Saito H, Ra C, Okayama Y. Nakashima-Kaneda K, et al. Int Arch Allergy Immunol. 2013;161 Suppl 2:44-51. doi: 10.1159/000350359. Epub 2013 May 29. Int Arch Allergy Immunol. 2013. PMID: 23711853

4

The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.

Chang TW, Chen C, Lin CJ, Metz M, Church MK, Maurer M. Chang TW, et al. J Allergy Clin Immunol. 2015 Feb;135(2):337-42. doi: 10.1016/j.jaci.2014.04.036. Epub 2014 Jun 17. J Allergy Clin Immunol. 2015. PMID: 24948369 Review.

5

Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells.

Mirzahosseini A, Dalmadi B, Csutora P. Mirzahosseini A, et al. Cell Immunol. 2013 May-Jun;283(1-2):38-44. doi: 10.1016/j.cellimm.2013.05.006. Epub 2013 Jun 4. Cell Immunol. 2013. PMID: 23850674

6

Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.

Mirkina I, Schweighoffer T, Kricek F. Mirkina I, et al. Immunol Lett. 2007 Apr 15;109(2):120-8. doi: 10.1016/j.imlet.2007.02.003. Epub 2007 Mar 1. Immunol Lett. 2007. PMID: 17368811

7

Cultured human mast cells are heterogeneous for expression of the high-affinity IgE receptor FcεRI.

Hoffmann HJ, Frandsen PM, Christensen LH, Schiøtz PO, Dahl R. Hoffmann HJ, et al. Int Arch Allergy Immunol. 2012;157(3):246-50. doi: 10.1159/000328756. Epub 2011 Oct 27. Int Arch Allergy Immunol. 2012. PMID: 22042057

8

An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.

Shiung YY, Chiang CY, Chen JB, Wu PC, Hung AF, Lu DC, Pan RL, Chang TW. Shiung YY, et al. Immunobiology. 2012 Jul;217(7):676-83. doi: 10.1016/j.imbio.2011.11.006. Epub 2011 Nov 25. Immunobiology. 2012. PMID: 22226669

9

The interaction between Lyn and FcεRIβ is indispensable for FcεRI-mediated human mast cell activation.

Okayama Y, Kashiwakura JI, Matsuda A, Sasaki-Sakamoto T, Nunomura S, Yokoi N, Ebihara N, Kuroda K, Ohmori K, Saito H, Ra C. Okayama Y, et al. Allergy. 2012 Oct;67(10):1241-9. doi: 10.1111/j.1398-9995.2012.02879.x.. Epub 2012 Jul 30. Allergy. 2012. PMID: 22845063

10

Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.

Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB. Prussin C, et al. J Allergy Clin Immunol. 2003 Dec;112(6):1147-54. doi: 10.1016/j.jaci.2003.10.003. J Allergy Clin Immunol. 2003. PMID: 14657874 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

376 results

Results by year